L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6

Modify Date: 2024-04-02 14:48:04

L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6 structure	Common Name	L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6
	CAS Number	1228077-86-8	Molecular Weight	188.7
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₆H₁₅ClN₂O₂	Melting Point	263-264 °C (dec.) (lit.)
	MSDS	N/A	Flash Point	N/A

Use of L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6

L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6 is the 13C labeled L-Lysine hydrochloride[1]. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health[2][3][4].

Name	l-lysine-13c6 hydrochloride

Description	L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6 is the 13C labeled L-Lysine hydrochloride[1]. L-lysine hydrochloride is an essential amino acid for humans with various benefits including treating herpes, increasing calcium absorption, reducing diabetes-related illnesses and improving gut health[2][3][4].
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Al-Malki AL, et al. Suppression of acute pancreatitis by L-lysinein mice. BMC Complement Altern Med. 2015 Jun 23;15:193. [3]. Baruffol C, et al. L-lysine dose dependently delays gastric emptying and increases intestinal fluid volume in humans and rats. Neurogastroenterol Motil. 2014 Jul26(7):999-1009. [4]. Shimomura A, et al. Dietary L-lysineprevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol. 2014 Sep25(9):1954-65.

Description

In Vitro

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].

References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.

[2]. Al-Malki AL, et al. Suppression of acute pancreatitis by L-lysinein mice. BMC Complement Altern Med. 2015 Jun 23;15:193.

[3]. Baruffol C, et al. L-lysine dose dependently delays gastric emptying and increases intestinal fluid volume in humans and rats. Neurogastroenterol Motil. 2014 Jul26(7):999-1009.

[4]. Shimomura A, et al. Dietary L-lysineprevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol. 2014 Sep25(9):1954-65.

Melting Point	263-264 °C (dec.) (lit.)
Molecular Formula	C₆H₁₅ClN₂O₂
Molecular Weight	188.7

WGK Germany	3

L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6

Use of L-Lysine-1,2,3,4,5,6(hydrochloride (1:1))-13C6

Names

Biological Activity

Chemical & Physical Properties

Safety Information